Harnessing Harm-Reduction Methods to Combat the Opioid CrisisFentanyl and fentanyl analogues, such as carfentanil, are driving an opioid overdose crisis in North America.1 In 2019 alone, there were 3831 opioid-related deaths in Canada and 47,600 fatalities involving opioids in the United States. The COVID-19 pandemic has only heightened the tragic impact of opioids on individuals who use the drugs, on their families, and on communities across both countries
Marijuana use at historic high among college-aged adults in 2020
Annual NIH-supported study reports changing substance use trends among college students and college-aged adults
Protective Factors Against Vaping and Other Tobacco Use
Vaping has gained popularity among adolescents despite negative health consequences. Few studies have focused on factors that may protect against vaping. We sought to determine if future orientation, parental monitoring, school connectedness, and social support are associated with decreased risk of vaping and other forms of tobacco use..
Judge conditionally approves plan to dissolve OxyContin maker Purdue Pharma
A federal bankruptcy judge ruled that Purdue Pharma, the maker of the addictive painkiller OxyContin, will be dissolved under a settlement deal and that its owners, members of the Sackler family, will pay out more than $4 billion to address the opioid epidemic that's killed more than 500,000 Americans.